Department of Ophthalmology, Taipei City Hospital Zhongxing Branch, Taipei, Taiwan.
Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Int J Med Sci. 2022 May 13;19(5):893-900. doi: 10.7150/ijms.73489. eCollection 2022.
The alteration of the exosomal proteins in the aqueous humor (AH) is linked to the development of eye diseases. The goal of this study was to examine the exosomal protein profile of patients with age-related macular degeneration (AMD) to better understand their role in the pathogenesis of AMD. Exosomes were isolated from the AH of 28 AMD and 25 control eyes. The quality, concentration, and size distribution of exosomes were measured using a nanoparticle tracking analysis system (NTA). Total exosomal proteins from each sample were purified and digested with trypsin for liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Based on LC-MS/MS analysis, we got 105 exosomal peptides from AMD and control patients. Gene ontology (GO) analysis in the biology process revealed that exosomal proteins of AMD were enriched in the lipoprotein metabolic process. T-test analysis revealed six exosomal proteins in patients with AMD were significantly different from controls. Comparing the exosomal protein profile of AMD patients who were receiving anti-VEGF therapy, we observed the amount of two proteins decreased with the duration of the anti-VEGF treatment time. In this study, we successfully isolated and purified AH exosomes. Our results provide pioneering findings for the exosomal protein profile in AMD development and under therapy. These unique proteins could be the new targets for drug discovery or biological markers for evaluating therapeutic efficacy.
房水中外泌体蛋白的改变与眼部疾病的发生有关。本研究旨在通过检测年龄相关性黄斑变性(AMD)患者的外泌体蛋白谱,以更好地了解其在 AMD 发病机制中的作用。 从 28 例 AMD 和 25 例对照眼的房水中分离出外泌体。使用纳米颗粒跟踪分析系统(NTA)测量外泌体的质量、浓度和粒径分布。 从每个样本的总外泌体蛋白中提取并使用胰蛋白酶消化,进行液相色谱-串联质谱(LC-MS/MS)分析。 根据 LC-MS/MS 分析,我们从 AMD 和对照患者中获得了 105 个外泌体肽。生物学过程中的基因本体(GO)分析表明,AMD 的外泌体蛋白富含脂蛋白代谢过程。T 检验分析显示,AMD 患者的 6 种外泌体蛋白与对照组有显著差异。比较接受抗 VEGF 治疗的 AMD 患者的外泌体蛋白谱,我们观察到两种蛋白的量随着抗 VEGF 治疗时间的延长而减少。 在这项研究中,我们成功地分离和纯化了房水外泌体。我们的结果为 AMD 发展和治疗中外泌体蛋白谱提供了开创性的发现。这些独特的蛋白质可能成为药物发现的新靶点或评估治疗效果的生物学标志物。